Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Minicircle plasmid DNA vector successfully treats liver disease in mice

Sep. 27, 2012

Results from first-in-human trial of Dz13 reported

Sep. 27, 2012

Novel PLK1 inhibitors show potent antiproliferative activity in vitro

Sep. 26, 2012

Novartis researchers identify novel orexin receptor antagonists for sleep disorders

Sep. 26, 2012

Melatonin identified as a marker of brain serotonin metabolism

Sep. 26, 2012

Herb-based lotion relieves symptoms of atopic dermatitis

Sep. 26, 2012

Benefits seen with rhLAMAN in patients with alpha-mannosidosis

Sep. 26, 2012

Sequestosome-1 identified as a biomarker of melanoma

Sep. 25, 2012

Eliglustat efficacy maintained for 4 years in patients with Gaucher's disease

Sep. 25, 2012

First-in-human study of Opal-HIV-Gag(c) terminated

Sep. 25, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...